Long on Meds Blog
What Is Inflammaging, and Why Does It Matter?
Inflammation itself is essential to health. A controlled inflammatory response helps us fight invading bacteria and viruses, repair injured tissue, and promote healing. The problem is not inflammation—it is inflammation that fails to turn off.
Inflammaging is the persistent, low-grade inflammatory activity that tends to increase with age. Instead of appearing briefly in response to injury or infection and then resolving, inflammatory signals remain chronically active. Over time, that persistent inflammatory pressure can contribute to disease, tissue damage, muscle loss, and loss of physical reserve.
Why does inflammaging matter as we get older?
Chronic inflammation is associated with many of the diseases that become more common with aging, including cardiovascular and metabolic disease. It can also contribute to sarcopenia—the age-related loss of muscle strength, muscle quantity or quality, and physical performance.
Muscle loss matters because muscle is part of our physical reserve. Maintaining strength and function helps us remain active, recover from illness or injury, avoid falls, and preserve independence.
The goal, therefore, is not to eliminate inflammation. It is to reduce unnecessary, persistent inflammatory pressure while preserving the inflammatory responses we need for normal health and healing.
What inflammatory pathways does Long on Meds examine?
Inflammation involves many interacting biological systems. Long on Meds focuses on three important pathways that are also influenced by a number of established medications:
Cytokine signaling / NF-κB: a signaling system that turns on and amplifies inflammatory messages.
NLRP3 inflammasome: a cellular alarm system that detects damage and stress and triggers inflammatory responses.
Oxidative stress / ROS: the balance between potentially damaging free radicals and the antioxidant systems that help neutralize them.
These are not the only pathways involved in inflammation, but they provide a practical framework for comparing medications.
Can medications influence these inflammatory pathways?
Yes. Many medications prescribed for common diseases also have evidence for a positive influence on one or more inflammatory pathways. Importantly, medications used to treat the same condition do not always have identical pathway effects.
This creates an opportunity to think more carefully about medication selection. If two drugs are both clinically appropriate, one may offer broader effects on inflammatory biology than the other.
Should inflammation determine which medication I take?
Clinical outcomes and safety come first. A medication should not be chosen simply because it has favorable effects on an inflammatory pathway.
Long on Meds first asks which medications have the strongest evidence for treating your disease and improving meaningful clinical outcomes. Inflammatory pathway evidence becomes an additional consideration when comparing otherwise appropriate choices.
How can I use this information?
Start with Check a Condition to see which medications have strong clinical evidence for the condition you are treating. Then use Check a Medication to compare your existing medications and see how they may influence the three inflammatory pathways.
If you identify a potentially better medication, use Print / Save as PDF for physician and take the report to your doctor.
The goal is not to eliminate inflammation or simply add more medications. It is to control disease while reducing unnecessary inflammatory pressure and preserving the organs, muscles, and physical reserve that help keep us healthy as we age.